Pre-analytical operating procedures for serum Low Molecular Weight protein profiling
Department of Laboratory Medicine and Advanced Biotechnologies, IRCCS San Raffaele Pisana, Rome, Italy.Journal of proteomics (Impact Factor: 3.89). 09/2009; 73(3):667-77. DOI: 10.1016/j.jprot.2009.09.006
Biological specimen collection and storage are an integral component of serum proteomics research. Although many efforts have been posed to address the effects of pre-analytical procedures, standardized protocols for collection and storage of samples for Low Molecular Weight (LMW) proteome profiling are still needed. Here we report a systematic analysis on the influence of pre-analytical factors [clotting times, temperature and time storage, addition of protease inhibitor (PI)] on serum LMW proteome profiling. Moreover, a comparison between manual versus automated peptide purification by functionalized magnetic bead-based MALDI-MS approach was performed. The results demonstrated best serum LMW proteins recovery and stability using a clotting time between 1 and 2h, with serum stored up to 2h either at room temperature or at 4 degrees C, independently of PI addition. PI addition to whole blood resulted in a lower number of LMW peaks detected. Finally, minimal effects on serum proteome profiles were observed after 1-month storage at -80 degrees C, independently of PI addition on whole blood and/or serum. In conclusion, the use of standardized pre-analytical and storage procedures together with an automated peptide purification might minimize potential bias on serum LMW profiling results, thus allowing a better homogeneity and reproducibility in future proteomics studies.
Article: Repressors of photomorphogenesis[Show abstract] [Hide abstract]
ABSTRACT: The internal programs of plant development are informed in a profound way by environmental light conditions. This review summarizes the contribution of repressor proteins to the light-signaling machinery during seedling development, and discusses the integration of repressors with other, positively acting, light-signaling pathways and auxin and brassinosteroid hormone-signaling pathways. The main focus is placed on the mode of action of the COP/DET/FUS proteins, which were first identified in Arabidopsis but are now emerging in other plants. Their role in regulating protein turnover through ubiquitination is reviewed in light of parallel ongoing investigations of COP/DET/FUS homologues in metazoans and fungi.International Review of Cytology 02/2002; 220:185-223. DOI:10.1016/S0074-7696(02)20006-6 · 9.00 Impact Factor
Conference Paper: BSIM4 high-frequency model verification for 0.13 μm RF-CMOS technology[Show abstract] [Hide abstract]
ABSTRACT: A compact model capable of simulating both DC and RF characteristics is highly desirable. This work is the first report of an extensive experimental evaluation of the accuracy of the BSIM4 model at high frequencies using a 0.13 μm RF-CMOS process. The accuracy of the model is verified on both N-channel and P-channel devices through small-signal S-parameter measurements up to 50 GHz, 1/f noise measurements, and noise figure measurements in the 2-GHz to 6-GHz range.Microwave Symposium Digest, 2004 IEEE MTT-S International; 07/2004
- [Show abstract] [Hide abstract]
ABSTRACT: Biobanks with their collections of clinical samples and data are essential resources for the success of clinical proteomics in delivering and validating candidate biomarkers. Samples must be banked in a manner that allows maximum subsequent compatibility with analytical techniques and additionally many critical factors must be taken into account when establishing a biobank or selecting samples from a biobank. These include logistical, ethical, legal and security issues and, very importantly, steps to minimise any pre-analytical variability introduced through sample processing and handling (technical effects). The inherent variation present within the samples must also be taken into account. In this review, we examine the impact of these factors and issues to be faced when banking samples with a particular focus on sources of pre-analytical variation, which must be rigorously controlled and recorded. It is encouraging that several initiatives are now addressing such key issues and these are also discussed.PROTEOMICS - CLINICAL APPLICATIONS 03/2010; 4(3):250-70. DOI:10.1002/prca.200900220 · 2.96 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.